XP-23829, a Novel Fumaric Acid Ester, is Efficacious in Reducing Psoriatic Lesions: Results from a Phase 2 Randomized Controlled Study. (2017). SKIN The Journal of Cutaneous Medicine, 1(3.1), s33. https://doi.org/10.25251/skin.1.supp.32